ALNYLAM PHARMACEUTICALS, INC. — Director's Dealing 2015

Apr 23, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ALNYLAM PHARMACEUTICALS, INC. (ALNY)
CIK: 0001178670
Period of Report: 2015-04-21

Reporting Person: Ausiello Dennis A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-04-21	Common Stock	S	8165.0	$130.02	Disposed	0	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3500	Indirect

Footnotes

F1: The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2014.

F2: The shares of ALNY common stock are held in a trust, of which the reporting person's spouse is the trustee.